Exozymes (EXOZ) EBT (QoQ) (2023 - 2025)
Exozymes (EXOZ) EBT (QoQ) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Exozymes | 62.92 Mn | 62.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.69% |
| Sep 30, 2025 | 3.11% |
| Jun 30, 2025 | -27.14% |
| Mar 31, 2025 | -1.00% |
| Dec 31, 2024 | -10.97% |
| Sep 30, 2024 | -21.94% |
| Jun 30, 2024 | -34.70% |
| Mar 31, 2024 | 4.53% |
| Dec 31, 2023 | -102.90% |